Cell therapy for Parkinson’s disease with induced pluripotent stem cells
Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disease and a prime target of cell therapies. In fact, aborted fetal tissue has been used as donor material for such therapies since the 1980s. These cell therapies, however, suffer from several problems, such as a short s...
Main Author: | Asuka Morizane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41232-023-00269-3 |
Similar Items
-
Can pluripotent/multipotent stem cells reverse Parkinson’s disease progression?
by: Yongkang Wu, et al.
Published: (2024-01-01) -
Challenges involved in cell therapy for Parkinson’s disease using human pluripotent stem cells
by: Heechang Moon, et al.
Published: (2023-10-01) -
The Role of E3s in Regulating Pluripotency of Embryonic Stem Cells and Induced Pluripotent Stem Cells
by: Yahong Wu, et al.
Published: (2021-01-01) -
Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells
by: Theo Stoddard-Bennett, et al.
Published: (2019-01-01) -
Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
by: David A Yefroyev, et al.
Published: (2022-01-01)